Interní Med. 2010; 12(11): 531-534

Insulin regimens from a clinical perspective

MUDr.Pavlína Piťhová
Interní klinika 2. LF UK a FN Motol, Praha

In order to provide insulin delivery, it is advisable to use a certain combination of various insulin preparations. Essentially, insulin

regimens can be divided into conventional (= administration of 1 or 2 injections/day of depot insulin or of a mixture of depot and shortacting

insulin) and intensified (= administration of 3 and more daily injections of short-acting and depot insulin + self-monitoring and

other measures) ones. Intensified insulin regimens also include the treatment with continuous subcutaneous insulin infusion using

an insulin pump. Selecting a particular type of insulin regimen depends on the levels of glycaemia in a particular patient – fasting hyperglycaemia

will most likely be managed by administering basal insulin at 10 pm whereas postprandial variation in glycaemia is best

managed by administering short-acting human insulin or a short-acting insulin analogue before the meal. There are numerous options

when selecting an insulin regimen. No matter which option is chosen, metabolic compensation is almost invariably achieved; however,

optimal control can only be achieved when the pathophysiological principles and individualisation of treatment are taken into account

in particular patients.

Keywords: insulin, conventional insulin regimen, intensified insulin regimen, insulin analogue

Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Piťhová P. Insulin regimens from a clinical perspective. Interní Med. 2010;12(11):531-534.
Download citation

References

  1. Porksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia 2002; 45(1): 3-20. Go to original source... Go to PubMed...
  2. Škrha J. Patogeneze inzulinové rezistence. Vnitřní lékařství 2003; 49(12): 894-899. Go to PubMed...
  3. White JR, Campbell RK, et al. Nové inzuliny a přísná kontrola glykemie. Medicína po promoci 2003, 4(5): 10-14.
  4. Garg SK. New insulin analogues. Diabetes Technology and Therapeutics 2005; 7(5): 813-881. Go to original source... Go to PubMed...
  5. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients - variations with increasing levels of HbA1c. Diabetes Care 2003; 26: 881-885. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.